GENFIT Announces Publication of Extra - Financial Performance Report 2022
A new report on liver diseases has been published by a leading biopharmaceutical company which aims to improve the lives of patients with rare and severe illnesses in Europe and the US. The BBC’s weekly The Boss series profiles different business leaders from around the world.
Source: itbusinessnet.comPublished on 2023-04-27
Related news
- ESG Investing – The Great Wall Street Money Heist – Investment Watch
- Take Corporate Climate Pledges of Net - Zero With a Healthy Dose of Skepticism • The Revelator
- ESG Weekly Update – January 5 , 2023 - Securities
- Gibson Energy Announces 2022 Fourth Quarter and Full Year Results and Announces 5 % Dividend Increase
- Nine developments and trends shaping US shareholder activism in 2023 | White & Case LLP
- Blockchain Laboratories Web3 Venture Studio On A Mission To ...
- The litigation and regulatory risks of ineffective climate change commitments
- Tuberville Returns With Call for Crypto Access in 401 ( k ) Plans
- Bank Of England : Minutes Of The Securities Lending Committee Meeting – November 2022
- Saudi exchange planning to launch single stock option in Q2 2023 : CEO
- Why corporate climate pledges of net - zero emissions should trigger a healthy dose of skepticism
- Oil Set To End The Year On A Bullish Note
- Euromoney Cop26 Sembcorp S$675 million SLB , Singapore
- Three Predictions for Climate Litigation in 2023 - Union of Concerned Scientists
- Major Toilet Paper Makers Are Wiping Out the Climate - Critical Boreal Forest